Scheduled maintenance

The RELX SDG Resource Centre is scheduled for maintenance on 16th July 2026. There may be a short period of downtime, expected to last no longer than 2 hours at some point during the day.

 

Thank you for your patience while we complete this work.

 

Treatment and Management of Tropical Liver Disease - Chapter 3: Hepatitis C infection

Elsevier, Treatment and Management of Tropical Liver Disease, 2025, Pages 17-23
Authors: 
Seid A.S., Shewaye A.B.

Hepatitis C virus (HCV) is hepatotropic viral hepatitis affecting the liver. It is mainly transmitted by percutaneous route with contact from sharp objects and blood products. Most patients are asymptomatic, and diagnosis is made by serologic tests followed by virologic confirmatory tests. The infection could result in chronic hepatitis and associated life-threatening complications such as decompensated cirrhosis and hepatocellular carcinoma (HCC). Extrahepatic manifestations (i.e., cryoglobulinemia, lichen planus, etc.) are more common than in other forms of viral hepatitis. Although not vaccine preventable, it can now be successfully treated with newly discovered oral directly acting antivirals (DAAs).